Scleroderma Flashcards
two things frequently seen in connective tissue diseases
raynaud’s phenomenon
non-erosie inflammatory arthritis– damaging surrounding structures not the joint itself
what is scleroderma
CTD characterized by sclerodactyly– skin thickening and tightening
- unilateral patches (morphea), en coup de sabre, linear scar tissue w/o injury
- negative antibodies, workup might be normal
localized scleroderma- sclerodactyly confined to skin and subcutaneous tissue
4 components of systemic sclerosis (SSC)
- sclerodactyly
- raynaud’s phenomenon
- internal organ involvement
- positive ANA
sex & ethnicity that scleroderma is most prevalent in
Females & african americans
what are the two arms of the disease? Inflammation leading to ____ and ____.
vasculopathy and fibrosis
when is immunosuppressive therapy used in scleroderma?
only in cutaneous & pulmonary manifestations
steroids are NOT normal treatments
what category of the disease does this fall under?
- face and distal to elbows & knees
- CREST
- associated w/ centromere antibody
- risk of pulmonary artery HTN
Limited cutaneous systemic sclerosis
what category of the disease does this fall under?
- distal + proximal regions– neck, arms, trunk & thighs
- associated w/ scl70 antibody
- risk of ILD
diffuse cutaneous systemic sclerosis
what category of the disease does this fall under?
- positive antibodies but no skin thickening
- still has other manifestations
sclerosis sine scleroderma
5 examples of fibrosis
- skin thickening/tightneing
- subcutaneous calcinosis
- salt & pepper hyperpigmentation
- GI dysmotility
- ILD
4 examples of vasculopathy
- cutaneous telangiectasias
- nailfold capillaroscopy
- digital ulceration and pitting in raynauds– sign that it is not primary raynauds
- watermelon stomach– AV malformations
1st line therapy for raynaud’s phenomenon
DHP CCBs— nifedipine XR, amlodipine
titrate up
2nd line therapy for raynaud’s
- PPD5 inhibitors– sildenafil
- alpha blockers– prazosin or ARBs like Lorsartan
tx of acute digital ischemia (2)
IV prostaglandins for 3 days
endothelin 1 receptor antagonists